HRD Evaluation and Scoring Using OncoScan CNV Assay - A Whole-Genome Microarray Research Solution
Offered By: Labroots via YouTube
Course Description
Overview
Explore homologous recombination deficiency (HRD) evaluation and scoring using the OncoScan CNV Assay in this informative webinar presented by Yann Christinat, PhD and Stephan Bartels, PhD. Learn about this whole-genome microarray research solution and its applications in identifying HRD as a genome-wide biomarker in high-grade ovarian and breast cancers. Discover how PARP inhibitors, a cancer therapeutic class, induce synthetic lethality in tumors with high levels of HRD. Gain valuable insights into the latest advancements in cancer research and potential therapeutic approaches during this 1-hour and 4-minute presentation.
Syllabus
HRD Evaluation and Scoring using OncoScan CNV Assay, a whole-genome microarray research solution
Taught by
Labroots
Related Courses
Introduction to Breast CancerYale University via Coursera Stratégies diagnostiques des cancers
Paris Diderot University via France Université Numerique Electronic Systems for Cancer Diagnosis
Indian Institute of Science Bangalore via Swayam Molecular Tumor Board 2020-21
University of Barcelona via Coursera ON DEMAND: Yale’s Review of Advances in Oncology Highlights from the ASCO® Annual Meeting 2021
Yale University via Independent